We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

3750:HKEXContemporary Amperex Technology Co., Limited Class H Analysis

Data as of 2026-06-19 - not real-time

HK$708.50

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Contemporary Amperex Technology is trading in a bullish technical environment, with price comfortably above its short‑term moving average and still above the mid‑term average, while the long‑term average remains lower, indicating an upward bias. The relative strength index sits near the neutral zone, suggesting limited upside momentum but no immediate oversold condition. Momentum indicators show a bearish divergence in the histogram, and volume has been tapering, which tempers short‑term enthusiasm. Fundamental metrics reveal a price‑to‑earnings multiple that exceeds the sector average, yet a discounted cash‑flow model points to a modest upside, and the dividend payout is minimal relative to earnings, supporting sustainability. Analyst coverage is broadly positive, with multiple buy recommendations and recent commentary highlighting untapped growth opportunities in battery technology and energy storage. Overall, the stock balances growth prospects against valuation premium, offering a cautiously optimistic outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish price positioning above short‑term averages
  • Decreasing volume and bearish histogram signal caution
  • Support level provides downside buffer

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF valuation indicates modest upside
  • Strong revenue growth and solid operating margins
  • Positive analyst sentiment and low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Leadership position in EV battery and energy‑storage markets
  • Secular demand growth for clean‑energy solutions
  • Sustainable dividend and manageable debt profile

Key Metrics & Analysis

Financial Health

Revenue Growth52.40%
Profit Margin16.87%
P/E Ratio35.0
ROE25.36%
Debt/Equity32.08
P/B Ratio7.8
Op. Cash FlowHK$134.0B
Industry P/E31.4

Technical Analysis

TrendBullish
RSI53.3
SupportHK$640.50
ResistanceHK$794.50
MA 20HK$706.35
MA 50HK$683.54
MA 200HK$559.91
MACDBearish
VolumeDecreasing
Fear & Greed Index92.14

Valuation

Fair ValueHK$792.05
Target PriceHK$759.17
Upside/Downside7.15%
GradeFair
TypeBlend
Dividend Yield0.50%

Risk Assessment

Beta0.56
Volatility47.04%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.